Top

Published in:

01-10-2020 | Buprenorphine | Concise Research Report

Financial Payments to Teaching Hospitals by Companies Marketing Opioids

Authors: Timothy S. Anderson, MD, MAS, Maxwell S. Krieger, BS, Brandon D. L. Marshall, PhD, Magdalena Cerdá, DrPH, MPH, Scott Hadland, MD, MPH, MS

Published in: Journal of General Internal Medicine | Issue 10/2020

Excerpt

Amid the national opioid overdose crisis, media reports and ongoing litigation have shed light on financial relationships between companies marketing opioid medications and teaching hospitals. Financial relationships between teaching hospitals and pharmaceutical companies may influence the education of trainees and physician prescribing practices, creating institutional conflicts of interest which can undermine public trust.¹ …

Institute of Medicine. Conflict of interest in medical research, education, and practice. National Academies Press; 2009. www.iom.edu/Reports/2009/Conflict-of-Interest-in-Medical-Research-Education-and-Practice.aspx.

Hadland SE, Cerdá M, Li Y, Krieger MS, Marshall BDL. Association of pharmaceutical industry marketing of opioid products to physicians with subsequent opioid prescribing. JAMA Intern Med. 2018;178(6):861–863.CrossRef

Fleischman W, Agrawal S, Gross CP, Ross JS. Association of pharmaceutical manufacturer payments to physicians and prescribing dosage of opioids. J Gen Intern Med. 2019;34(7):1074–1076.CrossRef

Centers for Medicare & Medicaid Services. Open Payments. https://www.cms.gov/openpayments/explore-the-data/dataset-downloads.html. Published 2019. Accessed April 28, 2019.

Food and Drug Administration. National Drug Code Directory. https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory, Published 2019. Accessed April 28, 2019.

Anderson TS, Good CB, Gellad WF. Industry payments to academic physicians: a comparison of reporting to two government agencies. J Gen Intern Med. 2018;33(10):1604–1606.CrossRef

Title: Financial Payments to Teaching Hospitals by Companies Marketing Opioids
Authors: Timothy S. Anderson, MD, MAS
Maxwell S. Krieger, BS
Brandon D. L. Marshall, PhD
Magdalena Cerdá, DrPH, MPH
Scott Hadland, MD, MPH, MS
Publication date: 01-10-2020
Publisher: Springer International Publishing
Keywords: Buprenorphine
Opioids
Opioids
Morphine
Oxycodone
Fentanyl
Published in: Journal of General Internal Medicine / Issue 10/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-019-05596-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Financial Payments to Teaching Hospitals by Companies Marketing Opioids

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2020

Secure Messaging, Diabetes Self-management, and the Importance of Patient Autonomy: a Mixed Methods Study

Readiness and Implementation of Quality Improvement Strategies Among Small- and Medium-Sized Primary Care Practices: an Observational Study

Mobile-Enhanced Peer Support for African Americans with Type 2 Diabetes: a Randomized Controlled Trial

Mobility and Mortality During the COVID-19 Pandemic

Student Education About Pre-exposure Prophylaxis (PrEP) Varies Between Regions of the United States

A Mixed-Methods Evaluation of Medical Residents’ Attitudes Towards Interprofessional Learning and Stereotypes Following Sonography Student-Led Point-of-Care Ultrasound Training

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page